Centre Hospitalier Universitaire de Liège (CHU Liège)

Overall survival (OS) results of the phase III MONALEESA-3 trial of postmenopausal patients (pts) with hormone receptor-positive (HR plus ), human epidermal growth factor 2-negative (HER2-) advanced breast cancer (ABC) treated with fulvestrant (FUL) (+) ribociclib (RIB) (2019) Slamon DJ, Neven P, Chia S, Fasching P, De Laurentiis M, Im SA, Petrakova K, et al. Conference contribution Multimodality imaging in cardiology: a statement on behalf of the Task Force on Multimodality Imaging of the European Association of Cardiovascular Imaging (2019) Fox K, Achenbach S, Bax J, Cosyns B, Delgado V, Dweck MR, Edvardsen T, et al. Journal article Estimating the effect size of the 15Q11.2 BP1-BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice (2019) Jønch AE, Douard E, Moreau C, Van Dijck A, Passeggeri M, Kooy F, Puechberty J, et al. Journal article Assessment of Muscle Function and Physical Performance in Daily Clinical Practice : A position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) (2019) Beaudart C, Rolland Y, Cruz-Jentoft AJ, Bauer JM, Sieber C, Cooper C, Al-Daghri N, et al. Journal article European myeloma network recommendations on tools for the diagnosis and monitoring of multiple myeloma: What to use and when (2018) Caers J, Garderet L, Kortuem KM, O'Dwyer ME, Van De Donk NWCJ, Binder M, Dold SM, et al. Journal article European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias (2018) Gavriatopoulou M, Musto P, Caers J, Merlini G, Kastritis E, Van De Donk N, Gay F, et al. Journal article, Review article Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN) (2018) Larocca A, Dold SM, Zweegman S, Terpos E, Waesch R, D'Agostino M, Scheubeck S, et al. Journal article, Review article Prevention and management of adverse events of novel agents in multiple myeloma: A consensus of the European Myeloma Network (2018) Ludwig H, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, et al. Journal article, Review article From transplant to novel cellular therapies in multiple myeloma: European myeloma network guidelines and future perspectives (2018) Gay F, Engelhardt M, Terpos E, Waesch R, Giaccone L, Auner HW, Caers J, et al. Journal article, Review article Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3 (2018) Slamon DJ, Neven P, Chia S, Fasching P, De Laurentiis M, Im SA, Petrakova K, et al. Journal article